India’s Implant Market to Reach USD 5 Billion by FY28 on Strong DemandIndia's orthopaedic and cardiac implant industry is likely to grow to USD 4.5–5 billion by FY2027-28, almost twice the size it is today at USD 2.4–2.7 billion in FY24...
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, today announced its earnings for the fourth quarter and full year FY25.
Helsinki Hospital Uses BNCT to Treat First Cancer PatientsNeutron Therapeutics LLC and Helsinki University Hospital have unveiled a groundbreaking milestone in treating cancer: the first patients in Europe have undergone accelerator-based boron...
The Subject Expert Committee (SEC), which advises India’s central drug regulatory authority on new drugs and clinical trials, has recommended that Biological E's COVID-19 vaccine
BioMarin to Acquire Inozyme Pharma for USD 270 MillionBioMarin Pharmaceutical, Inc. has publicly disclosed a definitive agreement to acquire Inozyme Pharma, Inc in an all-cash transaction of nearly USD 270 million...
74th Indian Pharmaceutical Congress 2025 Opens RegistrationsThe Indian Pharmaceutical Congress, 2025 (IPC), which is organized by the Association of Pharmaceutical Teachers of India (APTI), has opened its registration...
Sun Pharmaceutical Industries Limited reported that the U.S. Food and Drug Administration (FDA) has now approved premarket approval application (PMA) for the new, next generation BLU-U PDT Illuminator.
Scientists at the National Institutes of Health (NIH) have found that alterations in the structure and cell composition of breast connective tissue, or stroma, are associated with a heightened risk for aggressive breast cancer in women with benign...
Roche has announced FDA approval for the Ventana MET (SP44) RxDx Assay, emphasizing their first companion diagnostic designed to identify MET protein appearance in patients.
US President Donald Trump’s new price range for Rx drugs with other developed countries might not affect the generic companies in India.
, CDSCO.jpg)
